AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 110 filers reported holding AERIE PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.92 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $12,036,000 | +171.9% | 795,473 | +34.8% | 0.02% | +240.0% |
| Q2 2022 | $4,427,000 | -2.4% | 590,310 | +18.5% | 0.01% | 0.0% |
| Q1 2022 | $4,534,000 | +68.1% | 498,210 | +29.6% | 0.01% | +66.7% |
| Q4 2021 | $2,698,000 | -26.4% | 384,310 | +19.5% | 0.00% | -40.0% |
| Q3 2021 | $3,667,000 | -37.7% | 321,710 | -12.4% | 0.01% | -28.6% |
| Q2 2021 | $5,882,000 | +44.7% | 367,373 | +61.5% | 0.01% | +40.0% |
| Q1 2021 | $4,066,000 | +5.0% | 227,510 | -20.6% | 0.01% | +25.0% |
| Q4 2020 | $3,871,000 | +3.1% | 286,510 | -10.2% | 0.00% | 0.0% |
| Q3 2020 | $3,756,000 | -11.0% | 319,100 | +11.6% | 0.00% | 0.0% |
| Q2 2020 | $4,221,000 | +24.2% | 286,000 | +103.4% | 0.00% | +33.3% |
| Q4 2019 | $3,398,000 | +108.0% | 140,600 | +65.4% | 0.00% | +200.0% |
| Q3 2019 | $1,634,000 | -48.6% | 85,000 | -16.2% | 0.00% | -85.7% |
| Q1 2015 | $3,178,000 | – | 101,400 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|